Project Grant HT94252311068
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$5.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The Department of the Army Medical Command awarded a $7.286 million cooperative agreement to New York University School of Medicine to advance precision psychiatry for military service-related post-traumatic stress disorder (PTSD) by enhancing knowledge of clinical subtypes and their endophenotypes. Funded under the Military Medical Research and Development program (CFDA 12.420), this four-year cooperative agreement aims to transform military and public health care through innovative...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This federal Project Grant award of $424,175 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to better understand the genomic basis of post-traumatic stress disorder (PTSD). The research, conducted by Virginia Commonwealth University (VCU), will leverage existing large-scale whole exome sequencing (WES) and whole genome sequencing (WGS) datasets from the UK Biobank and All of Us Study to identify additional genetic signals...
This federal Project Grant award of $737,899 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Texas Health Science Center at San Antonio to develop a non-trauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The award has a performance period from September 1, 2024 to August 31, 2027. The project aims to...
This federal Project Grant award, valued at $3,141,404.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The awardee, Rush University Medical Center, a non-profit academic medical center located in Chicago, Illinois, will...
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
This $999,975.63 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a research initiative led by the Icahn School of Medicine at Mount Sinai (ISMMS) to investigate the molecular mechanisms underlying the increased vulnerability of the APOE4 gene variant to Alzheimer's disease and identify novel therapeutic targets. The award, with a performance period from April 1, 2025 to March 31, 2028, will...
The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
The Icahn School of Medicine at Mount Sinai will receive $1,678,688 under a four-year Project Grant from the Defense Health Agency's Military Medical Research and Development program to investigate the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. The research aims to transform military and public health through innovative medical solutions for the battlefield by supporting basic, applied, and advanced biomedical...